Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Finasteride may help some women with hair loss, but better options exist.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.